1-10 of 10
Matthew Cullen
Close
Sort by
Journal Articles

Clonal hematopoiesis is not significantly associated with COVID-19 disease severity

Clinical Trials & Observations
Yifan Zhou, Ruba Shalhoub, Stephanie N. Rogers, Shiqin Yu, Muxin Gu, Margarete A. Fabre, Pedro M. Quiros, Tae-Hoon Shin, Arch Diangson, Wenhan Deng, Shubha Anand, Wenhua Lu, Matthew Cullen, Anna L. Godfrey, Jacobus Preller, Jerome Hadjadj, Emmanuelle Jouanguy, Aurélie Cobat, Laurent Abel, Frederic Rieux-Laucat, Benjamin Terrier, Alain Fischer, Lara Novik, Ingelise J. Gordon, Larisa Strom, Martin R. Gaudinski, Andrea Lisco, Irini Sereti, Thomas J. Gniadek, Andrea Biondi, Paolo Bonfanti, Luisa Imberti, Clifton L. Dalgard, Yu Zhang, Kerry Dobbs, Helen C. Su, Luigi D. Notarangelo, Colin O. Wu, Peter J. M. Openshaw, Malcolm G. Semple, Ziad Mallat, Kenneth Baillie, Cynthia E. Dunbar, George S. Vassiliou
Journal: Blood
Blood (2022) 140 (14): 1650–1655.
https://doi.org/10.1182/blood.2022015721
Published: 2022
Includes: Supplemental data
Journal Articles

Multicenter Prospective Evaluation of Diagnostic Potential of Flow Cytometric Aberrancies in Myelodysplastic Syndromes

Wolfgang Kern, Theresia M. Westers, Frauke Bellos, Marie C Bene, Peter Bettelheim, Lisa Eidenschink Brodersen, Kate Burbury, Sung-Chao Chu, Matthew Cullen, Matteo Della Porta, Alan Stewart Dunlop, Ulrika Johansson, Sergio Matarraz, Uta Oelschlaegel, Kiyoyuki Ogata, Anna Porwit, Frank W. M. B. Preijers, Katherina Psarra, Leonie Saft, Dolores Subirá, Elisabeth Weiss, Arjan A. Van de Loosdrecht
Journal: Blood
Blood (2021) 138 (Supplement 1): 3995.
https://doi.org/10.1182/blood-2021-152298
Published: 2021
Journal Articles

The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis

Catherine Cargo, Matthew Cullen, Jan Taylor, Mike Short, Paul Glover, Suzan Van Hoppe, Alex Smith, Paul Evans, Simon Crouch
Journal: Blood
Blood (2019) 133 (12): 1325–1334.
https://doi.org/10.1182/blood-2018-08-867333
Published: 2019
Includes: Supplemental data
Journal Articles

Insights Into The Natural History Of Paroxysmal Nocturnal Hemoglobinuria (PNH): Analysis Of The Presenting Clinical, Haematological and Flow Cytometric Features Of 705 Patients Leads To Improved Classification and Prediction Of Clinical Course

Stephen John Richards, PhD, Richard Kelly, MD, Anita Hill, MBChB, PhD, Anita Dickinson, MSc, Fiona Cullen, MSc, Jane Shingles, PhD, Matthew Cullen, MSc, Peter Hillmen, MB ChB, PhD
Journal: Blood
Blood (2013) 122 (21): 3718.
https://doi.org/10.1182/blood.V122.21.3718.3718
Published: 2013
Journal Articles

Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Report of All 153 Patients Treated in the UK

Anita Hill, MBChB, PhD, Richard J Kelly, MBChB, Austin G Kulasekararaj, MBBS, MD, Shreyans A Gandhi, MBBS, MD, Lindsay D Mitchell, MBChB, Modupe Elebute, MBChB, MD, Stephen John Richards, PhD, Matthew Cullen, MSc, Louise M Arnold, RN, BSc, Joanna Large, RN, BSc, Alexandra Wood, RN, BSc, Gemma L Brooksbank, RN, BSc, Tracy Downing, Claire McKinley, BSc, Dena Cohen, BSc, MSc, Walter M Gregory, PhD, Judith C. W. Marsh, MD, PhD, Ghulam J. Mufti, MD, Peter Hillmen, MBChB, PhD
Journal: Blood
Blood (2012) 120 (21): 3472.
https://doi.org/10.1182/blood.V120.21.3472.3472
Published: 2012
Journal Articles

An In Vitro model of the Bone Marrow in Paroxysmal Nocturnal Hemoglobinuria Showing a Direct Effect of T-Cells within the Bone Marrow Allowing Clonal Expansion

Richard J Kelly, MBChB, FRCPath, Stephen John Richards, PhD, FRCPath, Matthew Cullen, MSc, Louise M Arnold, RN, BSc, hons, Gemma L Brooksbank, RN, BSc, hons, Anita Hill, MBChB, PhD, Reuben Tooze, PhD, Gina M Doody, PhD, Peter Hillmen, MBChB, PhD
Journal: Blood
Blood (2011) 118 (21): 731.
https://doi.org/10.1182/blood.V118.21.731.731
Published: 2011
Journal Articles

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival

CME
Richard J. Kelly, Anita Hill, Louise M. Arnold, Gemma L. Brooksbank, Stephen J. Richards, Matthew Cullen, Lindsay D. Mitchell, Dena R. Cohen, Walter M. Gregory, Peter Hillmen
Journal: Blood
Blood (2011) 117 (25): 6786–6792.
https://doi.org/10.1182/blood-2011-02-333997
Published: 2011
Journal Articles

Long Term Treatment with Eculizumab In Paroxysmal Nocturnal Hemoglobinuria (PNH): Sustained Efficacy and Improved Survival

Richard J Kelly, MBChB, MRCP(UK), FRCPath, Anita Hill, MBChB, MRCP(UK), FRCPath, PhD, Lindsay D Mitchell, MBChB, MRCP(UK), FRCPath, Stephen John Richards, PhD, FRCPath, Louise M Arnold, RN, BSc, hons, Gemma L Valters, RN, BSc, hons, Matthew Cullen, MSc, Dena R Cohen, MSc, Walter M Gregory, PhD, Peter Hillmen, MBChB, FRCP, FRCPath, PhD
Journal: Blood
Blood (2010) 116 (21): 639.
https://doi.org/10.1182/blood.V116.21.639.639
Published: 2010
Journal Articles

A Spontaneous Reduction of Clone Size in Paroxysmal Nocturnal Hemoglobinuria Patients Treated with Eculizumab for Greater Than 12 Months.

Richard Kelly, MBChB, Stephen Richards, PhD, Louise Arnold, BSc, MA, Gemma Valters, BSc, Matthew Cullen, MA, Anita Hill, MBChB, (Hons), PhD, Peter Hillmen, PhD
Journal: Blood
Blood (2009) 114 (22): 1992.
https://doi.org/10.1182/blood.V114.22.1992.1992
Published: 2009
Journal Articles

Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion

Andy C. Rawstron, Martin R. Yuille, Julie Fuller, Matthew Cullen, Ben Kennedy, Stephen J. Richards, Andrew S. Jack, Estella Matutes, Daniel Catovsky, Peter Hillmen, Richard S. Houlston
Journal: Blood
Blood (2002) 100 (7): 2289–2290.
https://doi.org/10.1182/blood-2002-03-0892
Published: 2002